E
Eledon Pharmaceuticals
ELDN
2.86000
USD
-0.033
(-1.14%)
مغلق
حجم التداول
21,830
الربح لكل سهم
0
العائد الربحي
0
P/E
12
حجم السوق
208,588,993
العنوان: Eledon Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.